AAVrh.10hFXN gene therapy

· Weill Medical College of Cornell University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AAVrh.10hFXN gene therapy, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia [Phase 1]